Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacological inhibition of glycolysis at the pyruvate-to-lactate conversion stage mitigates reperfusion injury without aggravating ischemic injury in mouse hearts

European Journal of Pharmacology(2026)10.1016/j.ejphar.2026.178740Source: DataRank Database

Pharmacological inhibition of glycolysis at the pyruvate-to-lactate conversion stage mitigates reperfusion injury without aggravating ischemic injury in mouse hearts is a research paper published in European Journal of Pharmacology (2026). On theSindex it has a DataRank of 0.104. It has been cited 1 time.

N/A

0.104DataRank · unranked

Scored on demand from live citation data

1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 6.74)OA: closedTopics (35)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.104

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (5)

Jun-Ming Tan,Hao-Nan Xing,Xiu-Ju Luo,Jun Peng ORCID,Bi-Feng Yao

Live enrichment

PubMed:41796842 OpenAlex:https://openalex.org/W7134117325

National Natural Science Foundation of China

Grant: 82073849

National Natural Science Foundation of China

Grant: 81872873

National Natural Science Foundation of China

Grant: 82173815

Hunan Provincial Natural Science Foundation

Grant: 2020JJ4770

Hunan Provincial Natural Science Foundation

Grant: 2021JJ30032

FWCI

6.74

Citation Percentile

0.9%

Citation Trend

2026

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S0014299926002220?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0014299926002220?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ejphar.2026.178740

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41796842

Fields of Study

Cardiac Ischemia and ReperfusionCongenital heart defects researchMitochondrial Function and PathologyMedicine

MeSH Terms

Metabolic ReprogrammingAnimalsDisease Models, AnimalEnergy MetabolismFatty AcidsGlucoseGlycolysisHexokinaseMaleMice, Inbred C57BLMyocardiumOxidation-ReductionMyocardial Reperfusion InjuryPyruvic AcidLactic AcidMyocytes, CardiacMice

Keywords

GlycolysisReperfusion injuryIschemiaDownregulation and upregulationHexokinaseBeta oxidationHypoxia (environmental)Lactate dehydrogenaseMyocardial ischemiaGlucose oxidationischemia/reperfusion injuryFatty Acid OxidationMetabolic UncouplingEnergy Metabolic Reprogramming

Sustainable Development Goals

SDG 0: Affordable and clean energy

Pharmacological inhibition of glycolysis at the pyruvate-to-lactate conversion stage mitigates reperfusion injury without aggravating ischemic injury in mouse hearts

FAIR Checklist

DataRank Breakdown

Authors (5)

Funding (5 grants)

Impact

Open Access

Topics